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Abstract: 
Giving coding region structural features a role in the hypomethylation of specific genes, the occurrence of G+C content, 
CpG islands, repeat and retrotransposable elements in demethylated genes related to cancer has been evaluated. A 
comparative analysis among different cancer types has also been performed. In this work, the inter-cancer coding region 
features comparative analysis carried out, show insights into what structural trends/patterns are present in the studied cancers. 
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Background: 
Alterations of DNA methylation have been recognized as 
an important component of cancer development [1]. 
Hypomethylation generally arises earlier and is linked to 
chromosomal instability and loss of imprinting [2-6], 
whereas hypermethylation is associated with promoters 
and can arise secondary to gene silencing [7-9], but might 
be a target for epigenetic therapy [10]. It is not currently 
known why certain CpG islands are hypermethylated or 
hyphometylated in specific cancers but not in others [1]. 
Some of these events have been observed in vitro and 
using in vivo animal models [2-4, 11, 12] but their relative 
importance in human disease is not understood. Recent 
studies suggest that some methylation patterns are 
discernible in risk groups and certain diseases. Indications 
are that the hypomethylation of specific DNA repeat 
elements or genes can be disease-specific [13].  These 
repeat sequences may be transposable elements found 
interspersed throughout the genome, or large repeat 
sequences and simple repeat ones, such as DNA satellites, 
that are found commonly in heterochromatin. 
 
Hypomethylation of satellites and retroelements together 
should account for the greater part of the decrease in 
methyl-cytosine content in cancer cells. Decreased 
methylation of single-copy genes does not contribute 
significantly to the decrease in quantity, but whether 
hypomethylation may lead to the reactivation of genes 
silenced in normal cells is an important issue. The site 
reported to be hypomethylated in several human cancers is 
located within the coding region. It may become 
demethylated in cancers as a consequence of global 
hypomethylation or may reflect increased transcriptional 
activity  [14, 15, 16]. The relationship between 
hypomethylation of specific genes and repeat elements 
within the genome may serve as useful diagnostic 
indicators for disease [13]. Nowadays, more information is 
required with regard to what repeat elements are specific to 
what diseases and whether this information can be used to 
predict disease onset or progression. Thus, the occurrence 
of G+C content, CpG islands, repeat and retrotransposable 
elements in demethylated genes related to cancer has been 
evaluated in this work. Moreover, a comparative analysis 
among different cancer types has also been performed in 
order to elucidate what structural trends/patterns are 
present in the studied cancers. 
 
Methodology: 
All selected genes were compiled from the recent literature 
(see Table 1 in supplementary material) and were collected 
from the NCBI nucleotide database [21]. The sequence 
characteristics of the coding regions of each gene were 
examined in the analysis. For CpG dinucleotide analysis, 
we used the NEWCPGREPORT program [17], and the 
total number of CpG islands was counted.  For the repeat 
element analysis, the Repeat Masker program [18] was 
used and for tandem repeat analysis, the ETANDEM 
program  [19]  was used.  All classes of repeat elements 
output from Repeat-Masker were collected. We used 
ETANDEM to obtain numbers of tandem repeat elements 
ranging from 5 bp to 100 bp. All the statistical calculations 
were performed using the Minitab software [20]. 
 
Discussion: 
Firstly, a list of genes that are demethylated in cancer 
according to the recent existing literature was compiled 
(Table 1 in supplementary material). We observed that 
these genes are related with 7 different cancer types: breast, 
colon, lung, ovarian, pancreatic, prostate and testicular. As 
it can be seen in Table 1, the ranges of genes affected by 
hypomethylation includes growth regulatory genes, 
enzymes, developmentally critical genes and tissue specific 
genes such as germ cell-specific tumour antigen genes, etc. 
Then, we selected 6 representative structural descriptors 
(variables) for the structural study: GC content, CpG 
islands, Simple Repeats (SR), Low Complexity (LC), 
Large Tandem Repeats (LTR) and SINE Alu. The [bp]% 
sequence characteristics of these descriptors were 
calculated for  all gene coding regions. As it has stated 
before, the site reported to be hypomethylated in several 
human cancers is located within the coding region [13, 15].  
For this reason, the structural information related with this 
region could be very useful in order to develop a first stage 
approximation. Once the values for all the structural 
descriptors were calculated, we performed a distribution 
analysis of the [bp]% differences across all 7 cancer types. 
In order to evaluate tendencies, we also calculated the Bioinformation by Biomedical Informatics Publishing Group                            open access 
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median and the average numbers for each descriptor and 
cancer types (see Figure 1).  
 
From the boxplot data comparisons in Figure 1, we 
observed how all the GC content, CpG islands, Simple 
Repeats (SR), Low Complexity Elements (LC) and Large 
Tandem Repeats (LTR) [bp] % average distributions 
follow the same trend in all the different cancers studied. 
In contrast, the SINE Alu [bp] % average distribution 
follows the opposite one. Apart form that, analyzing the 
value’s magnitude it can be observed that in general, the 
genes involved in the ovarian cancer show the smallest 
values for [bp] % and the largest value for the SINE Alu 
descriptor. On the other hand the major part of colon, 
pancreatic and prostate [bp] % values are the largest ones 
in all cases except for the SINE Alu descriptor (see Figure 
1). 
 
The relationship between CpG islands density and the GC 
content is logical taking into account that CpG islands are 
genomic regions that contain a high frequency of CG 
dinucleotides. Besides, the SR, LC and LTR elements 
follow the same CpG island trend while the SINE Alu 
follows the opposite one. To date, there seems to be very 
few comparative analyses of CpG islands density and their 
correlations with other genome features. Here, it seems 
clear that there is some structural mark/pattern that 
establishes a relationship among the different coding 
region features of the studied genes and so, a mark that 
relates different cancer types among them. After this 
preliminary approximation, we think that these 
observations would be related with different 
hypomethylation patterns observed in some specific 
cancers but not in others [1]. At this point, further 
investigation is required. Thus, we are studying the 
evolution of these trends in the sequences flanking the 
coding regions including the promoter sites. Our next 
objective will be the full identification of key structural 
characteristics that are unique to each cancer type. 
Moreover, a future detailed and extensive theoretical 
analysis of the methylation profiles of these sequences and 
their characteristics may reveal higher specificity and 
epigenetic signatures for cancer detection. 
 
 
Figure 1: Boxplot graphs (median and interquartile) with the comparison of the different [bp] % seuence characteristic 
distributions across the different cancer types*. Note that the different average numbers are connected by a drawing line. Bioinformation by Biomedical Informatics Publishing Group                            open access 
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Table 1: Hypo-methylated genes and their associated diseases 
 
 